NanoSphere Health Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NSHSF research report →
About the company
NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada. Its principal offering is the NanoSphere Deliver System, an advanced platform that leverages nanotechnology to enhance the biological absorption of supplements, nutraceuticals, and non-prescription drugs.
- CEO
- Michael Alexander Iverson
- IPO
- 2009
- Employees
- 3
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $102.75K
- P/E
- -1.76
- P/S
- 0.00
- P/B
- -0.11
- EV/EBITDA
- -0.94
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 6.14%
- ROIC
- 13.85%
- Revenue
- $0 · 0.00%
- Net Income
- $-86,266 · -32859.41%
- EPS
- $-0.01 · -134.43%
- Op Income
- $-181,907
- FCF YoY
- 34.90%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.55
- Avg Volume
- 13
Get TickerSpark's AI analysis on NSHSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NSHSF coverage
Recent articles, reports, and earnings notes.
No research on NSHSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NSHSF report →Similar companies
Peers in the same neighborhood.